Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...

The data from this prospective cohort study confirm and expand previous retrospective case series that have found factors, including hematologic cancers, chemotherapy receipt, and lung cancer, as ...

COVID-19 is rising in prevalence in many states nationally following the July 4 holiday week, but the role of the main therapy to treat it—the antiviral drug Paxlovid—is less clear.

An office worker surnamed Lee recently experienced high fever, chills, and muscle pain. At first, Lee thought it was just a summer cold or air conditioning sickness and took cold medicine. But ...

Dr. Amir Kol realized the striking parallels between FIP and severe COVID-19 could offer hope for millions of long COVID ...

COVID-19 activity is yet again on the rise in Hawaii, according to the latest report from the Hawaii Department of Health.

Despite offering significant protection against severe COVID-19, patients with cancer, a high-risk group, showed low uptake of booster vaccinations.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Citing prolonged custody, delay in trial, and parity with a co-accused, the Bombay High Court granted bail to businessman ...

A new study from Northwestern University found that life expectancy in California has not returned to pre-pandemic levels, ...

“Some people think that if they got the vaccine or feel healthy, they don’t need treatment,” said Karyne Jones, President and CEO of NCBA, Inc. and co-convener of CVEEP. “But that’s not always true.

Janus kinase (JAK) inhibitors are associated with decreased mortality and fewer serious adverse events among adults hospitalized with COVID-19.